admin,  —

Researchers at Temple University blocked the thromboxane brain cell receptor, stopping oxidative stress in an Alzheimer’s mouse model, and preventing key symptoms of the disease. In Alzheimer’s disease two pathological proteins accumulate in the brain: beta-amyloid protein and hyper-phosphorylated tau. Both are thought to wreak havoc by causing progressive…

A study conducted by a research team from the University of Oxford in England revealed preliminary data that point to a possible relationship between obesity and dementia, especially when people experience obesity in early to mid-adult ages, reported Pallavi Srivastava in an article for GIZMODO India (“How…

Playing certain types of computer games can be an effective alternative for treating elderly people diagnosed with depression whose symptoms exhibit resistance to conventional treatments, a new study showed. The study, titled “Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression” and published in the journal…

A research team from the University of Exeter Medical School and King’s College London has uncovered strong evidence of neurological epigenetic changes leading to Alzheimer Disease (AD) development. There are over 26 million people affected by AD worldwide, a chronic neurodegenerative disorder characterized by progressive neuropathology and cognitive decline. Despite…

Researchers from the Blanchette Rockefeller Neuroscience Institute (BRNI) have gathered evidence of the possible role of protein kinase C epsilon (PKCe) in the treatment of Alzheimer’s disease (AD). The news was recently announced by Neurotrope, a pharmaceutical company collaborating with BRNI in the development of bryostatin, a potent modulator of PKCe,…

The California Supreme Court recently decided, by a 5-2 decision, that people with Alzheimer’s disease cannot be held responsible for injuries caused to their in-home caregivers, and that a prior awareness of this fact precludes a legal accusation, CBS News recently reported, quoting an Associated Press report. According…

Researchers at Yale School of Medicine have discovered a new drug compound with the capacity to reverse the brain deficits of Alzheimer’s disease (AD) in an animal model. In this month’s issue of PLoS Biology, in an article entitled, “Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits…

A set of recent studies indicate that the rate of Alzheimer’s disease and other forms of dementia is decreasing in some of the wealthiest nations around the world — including the U.S. According to an article by David Green on The Legacy, research conducted in England,…

A simple test that measures how fast people walk and whether they have cognitive issues can determine how likely they are to develop dementia, which includes diseases such as Alzheimer’s, within 12 years. These are the conclusions of a study led by scientists at the Albert Einstein College of…

Recent results from Prana Biotechnology’s IMAGINE Alzheimer’s trial, released earlier this year (March), as well as the company’s ongoing sub-analysis, has suggested to the company’s research team that further analysis of the PiB-PET Standardized Uptake Value Ratio (SUVR) and the tendency towards preservation of brain volume in PBT2 treated patients may be necessary. The results…